Abstract
Evidence has accumulated that malignancy arises from maturation arrest of stem cells - rather than the dedifferentiation of somatic cells. To support this notion, stem cells in contrast to somatic cells are long lived cells and thus may become the subject of accumulating mutations that are crucial for the initiation/progression of cancer. More importantly they may maintain these mutations and pass them to daughter stem cells. Cancer stem cells (CSC) that derive from transformed normal stem cells (NSC) are responsible not only for tumor initiation, but also for its re-growth and metastasis. Accumulating evidence also indicates that adult tissues may contain a population of very small embryonic like (VSEL) stem cells that may give rise to some very immature tumors e.g., pediatric sarcomas. Similar molecular mechanisms operating in NSC and CSC regulate resistance to radio-chemotherapy and promote migration/metastasis. Thus, by studying the biology of NSC we can learn more about cancer. © Central European Science Journals Warsaw and Springer-Verlag Berlin Heidelberg. All rights reserved.
Author supplied keywords
Cite
CITATION STYLE
Ratajczak, M. Z., Kucia, M., Dobrowolska, H., Wanzeck, J., Reca, R., & Ratajczak, J. (2006). Emerging concept of cancer as a stem cell disorder. Central European Journal of Biology, 1(1), 73–87. https://doi.org/10.2478/s11535-006-0006-6
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.